Health & Fitness
AstraZeneca announces Β£13 billion deal for weight loss drugs
AstraZeneca with a site based in Speke has unveiled a tie-up with Chinaβs CSPC Pharmaceutical Group to ramp up development of experimental weight loss and diabetes drugs.